Latest / The BioHub - by Avetix
Episode 111 - Kevin Pojasek - President and CEO of Enara Bio
We were delighted to be joined by Kevin Pojasek who's the President and CEO of Enara Bio.
Enara Bio is shining a light on Dark Antigen and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients with solid tumors. There pioneering EDAPT® platform enables us to discover cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing library of Dark Antigens that can address the need for novel, cancer-specific targets in solid tumors.
In this we cover:
The spark that led to the founding of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.